Stockholders' Equity (Details Textual)								1 Months Ended							12 Months Ended
	Jun. 06, 2019	Apr. 17, 2019 $ / shares shares	Apr. 16, 2019	Mar. 06, 2019 USD ($) shares	Feb. 20, 2019 $ / shares shares	Feb. 15, 2019 USD ($) $ / shares shares	Aug. 15, 2018 USD ($) shares	Dec. 24, 2019 USD ($) shares	Aug. 16, 2019 USD ($) $ / shares shares	Jun. 27, 2019 USD ($) shares	May 22, 2019 shares	May 04, 2018 USD ($) shares	Mar. 23, 2018 USD ($) shares	Jan. 31, 2018 USD ($) shares	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2018 USD ($) $ / shares shares
Stockholders' Equity (Textual)
Aggregate grant fair value | $															$ 200,000
Warrants to purchase of common stock shares		50,000			50,000
Warrants exercise price | $ / shares		$ 0.01			$ 7.00
Unrecognized stock-based compensation expense | $															$ 4,000
Weighted average remaining contractual terms of unvested restricted stock															9 months 18 days
Preferred stock, shares authorized															5,000,000	5,000,000
Beneficially common stock outstanding, percentage									0.0499
Beneficial ownership limitation, percentage									0.0999
Common stock, par value | $ / shares															$ 0.0001	$ 0.0001
Issuance of shares									407,424
Net proceeds received | $									$ 1,600,000	$ 163
Restricted common stock of shares															40,000
Exercise warrant reduced										16,333	16,333
Common stock issued, description	The Company issued 47,605 shares of common stock upon the cashless exercise of warrants to purchase up to 57,750 shares of common stock.		The Company issued 176,272 shares of common stock upon the cashless exercise of warrants to purchase up to 215,747 shares of common stock. Those warrants were issued by the Company to Laidlaw pursuant to the terms of its engagement letter with Laidlaw with respect to the private placement of its securities from October 2017 through December 2017.
Stock issued for research and development | $																$ 36,000
Warrants to purchase									203,709							344,125
Preferred stock value | $
Warrants of stock holders equity, description			The Company estimated the relative fair value of the warrants at $0.8 million using the Black-Scholes option pricing model using the following primary assumptions: fair value of common stock underlying the warrants ranges from $2.55 to $4.33, expected life ranges from 2.0 to 5.0 years, volatility rate ranges from 107.30% to 110.08%, risk-free interest rate ranges from 1.42% to 1.48% and expected dividend rate of 0%.													The Company estimated the relative fair value of the warrants at $0.1 million using the Black-Scholes option pricing model using the following primary assumptions: fair value of common stock underlying the warrants is $0.16, expected life of 7.0 years, volatility rate of 75.0%, risk-free interest rate of 1.83% and expected dividend rate of 0%. Based on the warrant’s relative fair value to the fair value of the Series A Preferred Stock, approximately $0.2 million of the $1.2 million of aggregate fair value was allocated to the warrants, creating a corresponding preferred stock discount in the same amount.
Net of offering costs | $																$ 1,200,000
Exchange for issuance units | $																13.77
Fair value of the stock award | $															$ 1,012	$ 507
Granted an employee														25,000
Fair value of shares | $														$ 15,000
Restricted stock awards fair value, shares																37,500
Restricted stock awards fair value | $																$ 38,000
Restricted stock awards vested, description																12,500 shares of these restricted stock awards were vested immediately and 25,000 shares of these restricted stock awards were vested in 1/36 increments in monthly installments beginning August 3, 2018.
weighted average remaining contractual terms of unvested restricted stock awards															9 months 18 days
Stock-based compensation expense | $															$ 2,500,000	$ 100,000
Chief Executive Officer and Co-Founder [Member]
Stockholders' Equity (Textual)
Fair value of the stock award | $												$ 87,500
Nominal price of the shares | $												$ 87,500
Series A Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized															1,897,250	5,000,000
Preferred stock value | $																$ 310
Preferred stock outstanding | $															$ 0	$ 3,102,480
Investors [Member]
Stockholders' Equity (Textual)
Offering price per share | $ / shares									$ 5.00
Warrants exercise price | $ / shares									$ 8.00						$ 1
Gross proceeds | $									$ 2,037,120
2018 Equity Incentive Plan [Member]
Stockholders' Equity (Textual)
Aggregate grant fair value | $				$ 200,000				$ 2,000,000
Issuance of shares				50,000				475,000
Common stock reserved for issuance												1,000,000
Repurchase of issued common stock							31,513
Buyback common stock | $							$ 31,513
Buyback shares cancelled							31,513
2018 Equity Incentive Plan [Member] | Directors [Member]
Stockholders' Equity (Textual)
Issuance of shares of common stock, shares																25,000
Fair value of the stock award | $																$ 25,000
2018 Equity Incentive Plan [Member] | Scientific Advisory Board [Member]
Stockholders' Equity (Textual)
Fair value of the stock award | $													$ 11,000
Granted an employee													12,500
2018 Equity Incentive Plan [Member] | Non-Employee [Member]
Stockholders' Equity (Textual)
Options granted												12,500
Fair value of the stock award | $												$ 12,500
2018 Equity Incentive Plan [Member] | Employee [Member]
Stockholders' Equity (Textual)
Options granted												5,000
Fair value of the stock award | $												$ 5,000
Initial Public Offering [Member]
Stockholders' Equity (Textual)
Offering price per share | $ / shares						$ 5.60
Issuance of shares of common stock, shares						1,250,000
Shares of common stock						1,250,000
Net proceeds received | $						$ 5,800,000
Placement Agent Warrants [Member]
Stockholders' Equity (Textual)
Warrants to purchase of common stock shares									61,113
Placement Agent Warrants [Member] | Initial Exercise Date [Member]
Stockholders' Equity (Textual)
Warrants exercise price | $ / shares									$ 5.00
Convertible Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized															10,000,000
Preferred stock designated															5,000,000
Preferred stock converted into common stock															3,102,480
Preferred shares remain authorized															1,897,520